Immunotherapy in Treating Patients With Resected Liver Metastases From Colon Cancer
Ontology highlight
ABSTRACT: RATIONALE: Immunotherapy using CEA-treated white blood cells may help a person’s body build an immune response to kill their tumor cells.
PURPOSE: Phase I/II trial to study the effectiveness of immunotherapy with CEA-treated white blood cells in treating patients with resected liver metastases from colon cancer.
DISEASE(S): Neoplasm Metastasis,Colorectal Cancer,Metastatic Cancer
PROVIDER: 2002963 | ecrin-mdr-crc |
REPOSITORIES: ECRIN MDR
ACCESS DATA